Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma

Fig. 5

The relationship between this signature and chemotherapeutic efficacy and ICIs-related molecules. a Low-risk group had a higher IC50 of cisplatin, doxorubicin and mitomycin. b High-risk group was positively related with CTLA4, HAVCR2, LAG3, PDCD1 and TIGIT. c Low-risk group was negatively related with ICIs treatment represented by CTLA4-/PD-1-, CTLA4 + /PD-1-, CTLA4-/PD-1 + 

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us